about
Genetic variation of hepatitis B virus and its significance for pathogenesisPrevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and BotswanaEmergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in ChinaAnalysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countriesAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.Safety of tenofovir during pregnancy for the mother and fetus: a systematic review.Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Viral hepatitis and rapid diagnostic test based screening for HBsAg in HIV-infected patients in rural TanzaniaAccess to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy.Effects of gender and age on development of concurrent extrapulmonary tuberculosis in patients with pulmonary tuberculosis: a population based study.Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in CambodiaPostexposure prophylactic effect of hepatitis B virus (HBV)-active antiretroviral therapy against HBV infection.Occurrence of HBV/HIV coinfection by laboratory values in Roma, LesothoThe effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infectionThe role of co-infections in mother-to-child transmission of HIV.Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants.Hepatitis B virus epidemiology.HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in GabonHIV-Infected or -Exposed Children Exhibit Lower Immunogenicity to Hepatitis B Vaccine in Yaoundé, Cameroon: An Appeal for Revised Policies in Tropical Settings?The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma.Human immunodeficiency virus and viral hepatitis among high-risk groups: Understanding the knowledge gap in the Middle East and North Africa RegionSymptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease.Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Co-Infection Among HIV Infected Individuals at Tertiary Care Hospital in Western Nepal.Towards the elimination and eradication of hepatitis B.Response to hepatitis B vaccination among HIV-infected adults in Vietnam.HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patientsAntiviral drug discovery: broad-spectrum drugs from nature.Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature.Prophylaxis of vertical HBV infection.Congenital and perinatally-acquired infections in resource-constrained settings.Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis.High prevalence of syphilis, HBV and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital.HBV influence on Response to Antiretroviral Therapy in Horizontally HIV-HBV Coinfected Patient during Early Childhood.Hepatitis B Virus (HBV) Load Response to 2 Antiviral Regimens, Tenofovir/Lamivudine and Lamivudine, in HIV/ HBV-Coinfected Pregnant Women in Guangxi, China: The Tenofovir in Pregnancy (TiP) Study.HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals.Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
P2860
Q26772348-3339E7BD-D1DB-47E4-841B-31134B2E064BQ28546809-10ADF31F-B7FB-46D8-8686-BBAAAAB08FE6Q28547345-569DC7A6-F224-40FC-858D-C479E153CBC4Q28830093-8567A9AE-B6DB-4D2D-96BA-9753617E9999Q30391932-1C87B864-849F-4699-9A03-6DCC39097B71Q34213161-AD130BC8-1471-4B69-A0FC-55F75C930AC9Q34371989-ACE89A73-C593-428F-90F8-8B5B487A3FAFQ34405008-E9B6D2AF-8906-4EC5-A383-E7B976BF7B00Q34613499-86FE5EAE-1EA2-4B0E-BB00-F227DF3F4B2CQ34675557-DB45880B-7551-4149-ADEA-6B52254EB270Q34744900-EA9D32CE-2915-4581-9E46-7BB0C0281A63Q34827471-41CAA581-5124-40F1-93DA-2564BC59C5E5Q35095416-172335A3-3C90-420C-BD23-259D83FEE08DQ35105851-06122040-3548-44B4-8CC4-A7DD9937E46DQ35151271-4185EAB0-39C2-40B7-A043-D5CB3AF10B96Q35454587-D510F529-4B22-4743-8C0D-177B5A9DFCE3Q35542406-E36DC50F-5614-42F0-8D4B-4B72E3C0ED8AQ35542419-E0BC079B-6415-4CBC-AEAB-7BB587CAE08CQ35663834-1E037086-5EF9-443A-918B-848C370968C5Q35685474-7A9941C5-894C-49D5-B17F-2678EBAECDB3Q35893639-B2AAE519-5951-4B7A-98C1-ADA5C2AB5602Q36140481-8EFF36C4-A926-40A5-B59E-6A609B22D562Q36178032-27B10E66-C308-4519-B8BF-6DF3041254A1Q36254138-35B8248E-761F-4735-9324-99A57A2A1EBDQ36317694-0636AE00-4575-4BD8-B172-8D0B4DBF94CAQ36504266-9946FD32-9BD2-4E65-B673-4BC7F3AE11E3Q37098214-3771A953-FF70-4010-A5E8-0ED4DD496581Q37136221-4B93EA88-6C0B-4004-83A4-878E957294B4Q37409858-08927231-43AC-43DC-AA24-3C5C861AC6F2Q38260235-F28A89D7-DA1B-4026-9C7B-4C2A11634A48Q38406226-22BBF8DD-11B5-46A7-B054-BBCF810BE436Q38793776-260990A7-02DA-4956-97F7-BDF901711B7CQ38893286-E736FC7C-90F3-46CC-A508-379A5FACCE21Q38904188-394A0210-4ED5-4BC1-96D9-6FAF61336260Q39758143-CDEBFA5D-F041-4F03-88D4-484210B14768Q40089470-4DB1E78F-A64C-4AD3-A1B7-5AE1A171079AQ40187537-20AF8EC1-20F2-438D-BF3A-3FEA8A476AA0Q40530541-33F75809-8598-4DCE-A4E6-C7293E8C766AQ40627202-6F0B5F36-04C0-4491-B337-82CA6F98F553Q40648463-09070D93-FA66-4F39-ABB6-A9DB18E899B5
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HIV-HBV coinfection--a global challenge
@ast
HIV-HBV coinfection--a global challenge
@en
type
label
HIV-HBV coinfection--a global challenge
@ast
HIV-HBV coinfection--a global challenge
@en
prefLabel
HIV-HBV coinfection--a global challenge
@ast
HIV-HBV coinfection--a global challenge
@en
P2860
P50
P356
P1476
HIV-HBV coinfection--a global challenge
@en
P2093
P2860
P304
P356
10.1056/NEJMP1201796
P407
P577
2012-05-01T00:00:00Z